Properties of rapidly dissolving eutectic mixtures of poly(ethylene glycol) and fenofibrate: The eutectic microstructure

被引:114
作者
Law, D
Wang, WL
Schmitt, EA
Qiu, YH
Krill, SL
Fort, JJ
机构
[1] Abbott Labs, Abbott Pk, IL 60064 USA
[2] Boehringer Ingelheim Pharmaceut Inc, Pharmaceut Res & Dev, Ridgefield, CT 06877 USA
[3] Whitehall Robins Healthcare, Pharmaceut Res & Dev, Richmond, VA 23261 USA
关键词
eutectic; solid dispersion; fenofibrate; poly(ethylene glycol); eutectic microstructure;
D O I
10.1002/jps.10324
中图分类号
R914 [药物化学];
学科分类号
100701 [药物化学];
摘要
Poly(ethylene glycol) or PEG is an ideal inactive component for preparing simple binary eutectic mixtures because of its low entropy of fusion (similar to0.0076 J/mol-K), lower melting point (similar to62degreesC) compared to most pharmaceuticals, miscibility with drugs at elevated temperatures, and its covalent crystalline lattice. Implication of these physicochemical properties on eutectic crystallization and size reduction of the drug is discussed. Enhancement of the dissolution rate of a poorly soluble compound through the formation of PEG-drug eutectics was investigated using fenofibrate. Solid dispersions of PEG-fenofibrate when characterized, revealed that PEG and fenofibrate form a simple eutectic mixture containing 20-25%(w/w) fenofibrate at the eutectic point. Eutectic crystallization led to the formation of an irregular microstructure in which fenofibrate crystals were found to be less than 10 pm in size. Dissolution rate improvement of fenofibrate correlated with the phase diagram, and the amount of fenofibrate released from the dispersions that contained fenofibrate as a eutectic mixture was at least10-fold higher compared to untreated fenofibrate. On aging, the dissolution rate of the dispersion containing 15%(w/w) fenofibrate in PEG remained unaltered. The results indicate that PEG-drug eutectic formation is a valuable option for particle size reduction and subsequent dissolution rate improvement. (C) 2003 Wiley-Liss, Inc. and the American Pharmaceutical Association J Pharm Sci 92:505-515, 2003.
引用
收藏
页码:505 / 515
页数:11
相关论文
共 32 条
[1]
A COMPARATIVE BIOPHARMACEUTICAL STUDY OF FRESH AND AGING TOLBUTAMIDE POLYETHYLENEGLYCOLS SOLID DISPERSIONS [J].
ALONSO, MJ ;
MAINCENT, P ;
GARCIAARIAS, T ;
VILAJATO, JL .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1988, 42 (1-3) :27-33
[2]
MELTING BEHAVIOR OF LOW-MOLECULAR WEIGHT POLY (ETHYLENE-OXIDE) FRACTIONS .2. FOLDED CHAIN CRYSTALS [J].
BUCKLEY, CP ;
KOVACS, AJ .
COLLOID AND POLYMER SCIENCE, 1976, 254 (08) :695-715
[3]
MOLECULAR SEGREGATION AND NUCLEATION OF POLY(ETHYLENE OXIDE) CRYSTALLIZED FROM THE MELT .1. CALORIMETRIC STUDY [J].
CHENG, SZD ;
WUNDERLICH, B .
JOURNAL OF POLYMER SCIENCE PART B-POLYMER PHYSICS, 1986, 24 (03) :577-594
[4]
ENG KR, 2001, Patent No. 6180138
[5]
FORD JL, 1978, PHARM ACTA HELV, V53, P93
[6]
Thermal investigation of crystallization of polyethylene glycols in solid dispersions containing oxazepam [J].
Gines, JM ;
Arias, MJ ;
Moyano, JR ;
SanchezSoto, PJ .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1996, 143 (02) :247-253
[7]
GOLGBERG AH, 1966, J PAHRM SCI, V55, P484
[8]
GOLGBERG AH, 1966, J PHARM SCI, V55, P581
[9]
GOLGBERG AH, 1965, J PHARM SCI, V54, P1145
[10]
GOLGBERG AH, 1966, J PHARM SCI, V55, P487